Wells Fargo sees Eli Lilly (LLY) beating on rev/EPS during 1Q earnings
Tweet Send to a Friend
Wells Fargo analyst Mohit Bansal reiterated an Overweight rating and $375.00 price target on Eli Lilly (NYSE: LLY)."We see ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
